Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized trial of POF versus IF for advanced gastric cancer
ChiCTR-TRC-08000061Phase 3Recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Dec 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel, oxaliplatin, fluorouracil, folinic acid and irinotecan in gastric cancer (GC) and Esophago-Gastric Adenocarcinoma (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoints: overall survival, quality of life and 1 more. Started Dec 2007; status: recruiting.
02
Drugs
paclitaxeloxaliplatinfluorouracilfolinic acidirinotecan
03
Conditions
gastric cancer (GC)Esophago-Gastric Adenocarcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-08000061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000061.